| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
American Journal of Pathology, Vol 146, 239-249, Copyright © 1995 by American Society for Investigative Pathology
REGULAR ARTICLES |
AA van de Loo, OJ Arntz, AC Bakker, PL van Lent, MJ Jacobs and WB van den Berg
Department of Rheumatology, University Hospital St. Radboud, Nijmegen, The Netherlands.
The mechanism underlying the chronic and intermittent course of rheumatoid arthritis is not elucidated. In the present study, the role of interleukin 1 (IL-1) was investigated in exacerbations of antigen- induced arthritis in mice. A flare-up of smoldering inflammation (weeks 3 to 4 of antigen-induced arthritis) was inducible by injection of a small amount of methylated bovine serum albumin into the hypersensitive knee joint. Immunohistochemistry showed IL-1 expression in the synovial lining layer and in focal areas of the inflamed synovium during the flare-up. IL-1 was also measured in 1-hour culture supernatant of synovial tissue taken during the flare-up by a bioassay. The expression of both immunoreactive and bioactive IL-1 in the hypersensitive joint peaked around 6 hours after antigen (2 micrograms of methylated bovine serum albumin) injection and declined thereafter. Antigen rechallenge induced an acute joint swelling of the arthritic joint but not in the naive joint of the sensitized mouse, yet synovia of both joints produced IL-1 after antigen injection. Remarkably, a single intravenous injection of rabbit anti-IL-1 alpha and -beta antibodies 1 hour before antigen rechallenge neutralized IL-1 in the joint. Anti-IL-1 treatment significantly reduced the antigen-induced joint swelling (30 to 40%) but did not affect the profound influx of polymorphonuclear cells in the onset of the exacerbation. However, a profound relief of the inflammation (synovitis) was obtained by IL-1 blockade on day 4 of the exacerbation. Chondrocyte proteoglycan synthesis was markedly suppressed in the antigen-challenged naive knee joints suggesting that this was a direct IL-1 effect as the inflammation was insignificant. Anti-IL-1 treatment was able to maintain chondrocyte proteoglycan synthesis in the antigen-rechallenged joint, which was highly suppressed in the control group. Furthermore, the enhanced proteoglycan breakdown in the antigen-rechallenged joints was significantly decreased in the anti-IL-1 group. We concluded that IL-1 is an important mediator in exacerbations of murine arthritis, and amelioration of cartilage pathology was obtained with anti-IL-1 antibody treatment.
This article has been cited by other articles:
 |
|
 |
|
  M. I. Koenders, E. Lubberts, B. Oppers-Walgreen, L. van den Bersselaar, M. M. Helsen, F. E. Di Padova, A. M.H. Boots, H. Gram, L. A.B. Joosten, and W. B. van den Berg Blocking of Interleukin-17 during Reactivation of Experimental Arthritis Prevents Joint Inflammation and Bone Erosion by Decreasing RANKL and Interleukin-1 Am. J. Pathol., July 1, 2005; 167(1): 141 - 149. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. Bolon, G. Campagnuolo, L. Zhu, D. Duryea, D. Zack, and U. Feige Interleukin-1{beta} and Tumor Necrosis Factor-{alpha} Produce Distinct, Time-dependent Patterns of Acute Arthritis in the Rat Knee Vet. Pathol., May 1, 2004; 41(3): 235 - 243. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P Miossec Anti-interleukin 1{alpha} autoantibodies Ann Rheum Dis, July 1, 2002; 61(7): 577 - 579. [Full Text] [PDF]
|
|
|
|
 |
|
 P. J. Richards, B. D. Williams, and A. S. Williams Suppression of chronic streptococcal cell wall-induced arthritis in Lewis rats by liposomal clodronate Rheumatology, September 1, 2001; 40(9): 978 - 987. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Cunnane, A. Madigan, E. Murphy, O. FitzGerald, and B. Bresnihan The effects of treatment with interleukin-1 receptor antagonist on the inflamed synovial membrane in rheumatoid arthritis Rheumatology, January 1, 2001; 40(1): 62 - 69. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. B van den Berg Arguments for interleukin 1 as a target in chronic arthritis Ann Rheum Dis, November 1, 2000; 59(90001): i81 - 84. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J B J van Meurs, P L E M van Lent, A A J van de Loo, A E M Holthuysen, E K Bayne, I I Singer, and W B van den Berg Increased vulnerability of postarthritic cartilage to a second arthritic insult: accelerated MMP activity in a flare up of arthritis Ann Rheum Dis, June 1, 1999; 58(6): 350 - 356. [Abstract] [Full Text]
|
|
|
|
 |
|
 M. G. Netea, B. Jan Kullberg, O. C. Boerman, I. Verschueren, C. A. Dinarello, and J. W. M. Van der Meer Soluble Murine IL-1 Receptor Type I Induces Release of Constitutive IL-1{alpha} J. Immunol., April 15, 1999; 162(8): 4876 - 4881. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
